Ascendis Pharma (Brazil) Investor Sentiment

A1SN34 Stock  BRL 56.10  0.00  0.00%   
About 56% of Ascendis Pharma's investor base is looking to short. The analysis of current outlook of investing in Ascendis Pharma AS suggests that many traders are alarmed regarding Ascendis Pharma's prospects. The current market sentiment, together with Ascendis Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Ascendis Pharma AS stock news signals to limit their universe of possible portfolio assets.
  
over six months ago at news.google.com         
Heres How Much 1000 Invested In Ascendis Pharma 15 Years Ago Would Be Worth Today - Ascendis Pharma ...
Google News at Macroaxis
over six months ago at news.google.com         
Hennion Walsh Asset Management Inc. Boosts Holdings in Ascendis Pharma AS - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Ascendis Pharma AS Shares Gap Up to 129. - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
GAMMA Investing LLC Buys 102 Shares of Ascendis Pharma AS - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Ascendis Pharma AS Stock Rating Upgraded by TD Cowen - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Ascendis Pharma ADR Shows Improved Relative Price Performance Still Shy Of Benchmark - Investors Bus...
Google News at Macroaxis
over six months ago at news.google.com         
Need To Know Analysts Are Much More Bullish On Ascendis Pharma AS Revenues - Yahoo Movies UK
Google News at Macroaxis
over six months ago at news.google.com         
Trading Advice - Stock Traders Daily
Google News at Macroaxis
over six months ago at news.google.com         
Should You Buy Ascendis Pharma Ahead of Earnings - Yahoo Lifestyle UK
Google News at Macroaxis
over six months ago at news.google.com         
Wellington Management Group LLP Decreases Stake in Ascendis Pharma AS - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
BofA awaits TransCon PTH review outcome, reiterates buy on Ascendis Pharma stock By Investing.com - ...
Google News at Macroaxis
over six months ago at news.google.com         
Sei Investments Co. Has 45.57 Million Holdings in Ascendis Pharma AS - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Avoro Capital Advisors LLC Increases Stock Holdings in Ascendis Pharma AS - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Trend Tracker for - Stock Traders Daily
Google News at Macroaxis
over six months ago at news.google.com         
Ascendis Pharma AS Short Interest Down 6.5 percent in May - Defense World
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Ascendis Pharma that are available to investors today. That information is available publicly through Ascendis media outlets and privately through word of mouth or via Ascendis internal channels. However, regardless of the origin, that massive amount of Ascendis data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ascendis Pharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ascendis Pharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ascendis Pharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ascendis Pharma alpha.

Ascendis Pharma Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Ascendis Stock analysis

When running Ascendis Pharma's price analysis, check to measure Ascendis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascendis Pharma is operating at the current time. Most of Ascendis Pharma's value examination focuses on studying past and present price action to predict the probability of Ascendis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascendis Pharma's price. Additionally, you may evaluate how the addition of Ascendis Pharma to your portfolios can decrease your overall portfolio volatility.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets